BridgeMD
Tests treatment safety and results for Hypertension
Official title Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
ClinicalTrials.gov ID: NCT05168605
What this study is testing
- What it's testing
- The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Adult patients ages 18-60
- Spanish or English speaking
- Diagnosis of HTN or BP \>140/90 in last 3 months (based on medical record)
- Hemoglobin A1C\>8 in last 6 months (based on medical record)
- Not pregnant
You likely can't join if
- Current oral steroid use
- History of solid organ transplant
- Language other than English or Spanish
The study team makes the final eligibility decision.
Where it's taking place
- Dallas, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dallas, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.